Life Healthcare announces interim results and dividend increase

Life Healthcare Group Holdings Limited (JSE:LHC) today announced its condensed unaudited interim results for the six months ended March 31, 2025, demonstrating robust activity with paid patient days (PPDs) up 2.0% and occupancy at 68.6%. Revenue from continuing operations grew by 8.1% to ZAR 12.1 billion, and normalised earnings per share (NEPS) increased by 9.1% to 49.0 cents. The Board has declared an interim cash dividend of 21.0 cents per share. The company expects the Life Molecular Imaging (LMI) transaction to close in H2 2025. The southern African business will continue to optimize its underlying asset portfolio and focus on operational efficiencies, with capex for FY2025 expected to be ZAR 2.3 billion. The company noted total number of issued ordinary shares is 1 467 349 162.